Table 5. Impact of the grand convergence investment case on low and middle income countries*.
| Baseline 2011 | Constant coverage scenario 2030 | Enhanced investment scenario 2030 | Enhanced investment scenario with R&D 2030 | Events averted by enhanced investment in 2030 | |
|---|---|---|---|---|---|
| A | B | C | D | B-D | |
| RMNCH | |||||
| Births, thousands | 87,641 | 115,000 | 75,250 | 75,250 | 39,750 |
| Total Fertility Rate | 3.2 | 3.3 | 2.2 | 2.2 | |
| Maternal deaths, thousands | 269 | 388 | 95 | 63 | 325 |
| Stillbirths, thousands | 2,067 | 2,825 | 1,100 | 750 | 2,075 |
| Neonatal deaths (0–27 days), thousands | 2,647 | 3,575 | 645 | 425 | 3,150 |
| Child deaths (1–59 months), thousands | 4,010 | 5,950 | 1,325 | 900 | 5,050 |
| Total Under 5 Child deaths, thousands | 6,657 | 9,525 | 1,975 | 1,325 | 8,200 |
| Under-5 mortality Rate, deaths per 1000 births | 76 | 83 | 26 | 18 | 65 |
| Maternal Mortality Rate, deaths per 100,000 births | 307 | 337 | 126 | 84 | 254 |
| Tuberculosis | |||||
| New cases, thousands | 6,297 | 5,925 | 2,900 | 1,950 | 3,975 |
| Deaths, thousands | 1,135 | 1,090 | 250 | 160 | 930 |
| New infections, thousands | 1,581 | 2,425 | 350 | 235 | 2,190 |
| Deaths aged 5 and over, thousands | 1,166 | 1,725 | 175 | 120 | 1,605 |
| Total HIV/AIDS & TB deaths, thousands | 2,056 | 2,500 | 375 | 250 | 2,250 |
| Total deaths, thousands | 11,049 | 15,238 | 3,540 | 2,388 | 12,850 |
*Data presented are rounded.